Abstract
Acquired hemophilia is characterized by the development of antibodies to coagulation proteins. Although these inhibitors are rare, they pose serious threats to health as a result of their ability to produce spontaneous hemorrhage. As these inhibitors occur infrequently, epidemiological analyses of their patterns of occurrence, details of clinical presentations, and practical management of acute hemorrhage are difficult to gather. In an effort to augment the clinical data base, we reviewed the records of 26 patients treated at our institution from 1980 to 1993.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
. Green, D., and Lechner, K., A survey of 215 non-hemophilic patients with inhibitors to Factor VIII, Thromb Haemost. 45: 200 (1981).
. Lottenberg, R., Kentro, T.B., and Kitchens, C.S., Acquired hemophilia. A natural history study of 16 patients with Factor VIII inhibitors receiving little or no therapy, Arch Intern Med. 147: 1077 (1987).
. Soriano, R.M., Matthews, J.M., and Guerado-Parra, E., Acquired hemophilia and rheumatoid arthritis, Br J. Rheumatol. 26: 381 (1987).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Plenum Press, New York
About this chapter
Cite this chapter
Moliterno, A., Bell, W.R. (1995). Clinical presentation and management of patients with circulating anticoagulants. In: Aledort, L.M., Hoyer, L.W., Lusher, J.M., Reisner, H.M., White, G.C. (eds) Inhibitors to Coagulation Factors. Advances in Experimental Medicine and Biology, vol 386. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0331-2_13
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0331-2_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-8001-6
Online ISBN: 978-1-4613-0331-2
eBook Packages: Springer Book Archive